Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001231919-25-000018
Filing Date
2025-01-27
Accepted
2025-01-27 17:04:53
Documents
1
Effectiveness Date
2025-01-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12903
  Complete submission text file 0001231919-25-000018.txt   14195
Mailing Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830
Business Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: D | Act: 33 | File No.: 021-536382 | Film No.: 25559956
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)